|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 5/0775 | |
| A61K 35/28 | |||
| A61P 13/12 | |||
| A61P 9/00 | |||
| A61K 9/00 | |||
| A61K 31/7028 |
| (11) | Number of the document | 2931876 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13862555.3 |
| Date of filing the European patent application | 2013-12-12 | |
| (97) | Date of publication of the European application | 2015-10-21 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/AU2013/001452 |
| Date | 2013-12-12 |
| (87) | Number | WO 2014/089623 |
| Date | 2014-06-19 |
| (30) | Number | Date | Country code |
| 201261736361 P | 2012-12-12 | US |
| (72) |
KIMPTON, Wayne Gregory, AU
BAILEY, Simon Reeves, AU
ITESCU, Silviu, AU
GHOSH, Peter, AU
|
| (73) |
Mesoblast, Inc.,
505 Fifth Avenue Third Floor, New York, NY 10017,
US
|
| (54) | TREATMENT OF DISEASES OF ENDOTHELIAL DYSFUNCTION AND INFLAMMATION |
| TREATMENT OF DISEASES OF ENDOTHELIAL DYSFUNCTION AND INFLAMMATION |